Skip to main content
. 2020 Apr 2;10:5797. doi: 10.1038/s41598-020-62680-x

Table 1.

Patient’s characteristics.

Variables SAP (n = 56) ACS (n = 144) Control (n = 57) P value
Age (years) 61.3 ± 9.1 59.9 ± 12.5 45.6 ± 11.1 0.001
Sex (%)
Male (n = 123) 42.8 54.9 35.1 0.02
Female (n = 134) 57.2 45.1 64.9
BMIa (Kg/m2) 25 ± 3.7 24.9 ± 4.3 25.8 ± 4.3 0.4
Waist (cm) 89.3 ± 13 91.3 ± 14.9 84.1 ± 15.9 0.005
Systolic blood pressure (mmHg) 138.2 ± 20.8 135.9 ± 23.1 127.7 ± 9.3 0.01
Diastolic blood pressure (mmHg) 81.1 ± 16.3 83.9 ± 41 76.9 ± 5.1 0.3
bLDL cholesterol (mg/dL) 86.4 ± 27.4 102.6 ± 95.9 117.7 ± 42.1 0.09
cHDL cholesterol (mg/dL) 44.1 ± 11.1 41.9 ± 10.6 46.7 ± 15.5 0.03
Total cholesterol (mg/dL) 150.9 ± 36.4 157 ± 45.4 183.7 ± 40.2 0.003
Triglyceride (mg/dL) 125.5 ± 59.2 127.8 ± 76.9 93.6 ± 33.7 0.003
dFBS (mg/dL) 131 ± 51.1 129.9.9 ± 56.8 98.2 <0.0001
Smoking (%) 13 22.2 11.1 0.003
eLVEF (%) 50 ± 15.5 46.4 ± 9.8 0.2
Gensini score 32.4 ± 35.2 56.3 ± 47.8 <0.0001
Medical treatment (%)
Aspirin 71.2 49.4 0.0 <0.0001
Beta-blocker 27.3 24.5 0.0 <0.0001
fACEI 12.1 11.9 0.0 0.016
Statin 50 33.3 0.0 <0.0001
Nitrate 50 26.9 0.0 <0.0001
gCCB 10.6 5.6 0.0 <0.0001
hs-CRP (μg/mL) 185 ± 144.7# 262 ± 198.8*# 147.6 ± 137.1 0.001

aBMI, body mass index; bLDL, low density lipoprotein; cHDL, high density lipoprotein; dFBS, fasting blood sugar; eLVEF, left ventricular ejection fraction; fACEI, angiotensin-converting enzyme inhibitor; gCCB, Calcium channel blocker.

*P < 0.05 versus control.

#P = 0.047.